Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The pathogenetic significance of exhausted T cells in a mouse model of mature B cell neoplasms.
Shibamiya A, Miyamoto-Nagai Y, Koide S, Oshima M, Rizq O, Aoyama K, Nakajima-Takagi Y, Kato R, Kayamori K, Isshiki Y, Oshima-Hasegawa N, Muto T, Tsukamoto S, Takeda Y, Koyama-Nasu R, Chiba T, Honda H, Yokote K, Iwama A, Sakaida E, Mimura N. Shibamiya A, et al. Among authors: kayamori k. Cancer Immunol Immunother. 2023 Aug;72(8):2635-2648. doi: 10.1007/s00262-023-03447-x. Epub 2023 Apr 17. Cancer Immunol Immunother. 2023. PMID: 37069353 Free PMC article.
Genetic and transcriptional landscape of plasma cells in POEMS syndrome.
Nagao Y, Mimura N, Takeda J, Yoshida K, Shiozawa Y, Oshima M, Aoyama K, Saraya A, Koide S, Rizq O, Hasegawa Y, Shiraishi Y, Chiba K, Tanaka H, Nishijima D, Isshiki Y, Kayamori K, Kawajiri-Manako C, Oshima-Hasegawa N, Tsukamoto S, Mitsukawa S, Takeda Y, Ohwada C, Takeuchi M, Iseki T, Misawa S, Miyano S, Ohara O, Yokote K, Sakaida E, Kuwabara S, Sanada M, Iwama A, Ogawa S, Nakaseko C. Nagao Y, et al. Among authors: kayamori k. Leukemia. 2019 Jul;33(7):1723-1735. doi: 10.1038/s41375-018-0348-x. Epub 2019 Jan 11. Leukemia. 2019. PMID: 30635632
Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a retrospective single-institution analysis.
Takaishi K, Tsukamoto S, Ohwada C, Takeuchi M, Kawasaki Y, Nagai Y, Mishina T, Yamazaki M, Isshiki Y, Kayamori K, Kimura K, Hino Y, Oshima-Hasegawa N, Mitsukawa S, Takeda Y, Mimura N, Iseki T, Nakaseko C, Sakaida E. Takaishi K, et al. Among authors: kayamori k. J Thromb Thrombolysis. 2019 Jul;48(1):141-148. doi: 10.1007/s11239-019-01809-w. J Thromb Thrombolysis. 2019. PMID: 30673940
T315I mutation with lymphoblasts in a newly diagnosed patient with chronic-phase chronic myeloid leukemia.
Kimura K, Tsukamoto S, Takaishi K, Isshiki Y, Kayamori K, Hino Y, Ohshima-Hasegawa N, Mitsukawa S, Takeda Y, Mimura N, Takeuchi M, Ohwada C, Iseki T, Nakaseko C, Sakaida E. Kimura K, et al. Among authors: kayamori k. Leuk Lymphoma. 2019 Jun;60(6):1591-1594. doi: 10.1080/10428194.2018.1548704. Epub 2019 Jan 16. Leuk Lymphoma. 2019. PMID: 31161870 No abstract available.
Suppressive effects of anagrelide on cell cycle progression and the maturation of megakaryocyte progenitor cell lines in human induced pluripotent stem cells.
Takaishi K, Takeuchi M, Tsukamoto S, Takayama N, Oshima M, Kimura K, Isshiki Y, Kayamori K, Hino Y, Oshima-Hasegawa N, Mitsukawa S, Takeda Y, Mimura N, Ohwada C, Iseki T, Nakamura S, Eto K, Iwama A, Yokote K, Nakaseko C, Sakaida E. Takaishi K, et al. Among authors: kayamori k. Haematologica. 2020 May;105(5):e216-e220. doi: 10.3324/haematol.2018.214841. Epub 2019 Sep 5. Haematologica. 2020. PMID: 31488559 Free PMC article. No abstract available.
Successful second autologous stem-cell transplantation for patients with relapsed and refractory POEMS syndrome.
Shibamiya A, Ohwada C, Ishii A, Mishina T, Nagai Y, Hino Y, Kayamori K, Oshima-Hasegawa N, Muto T, Tsukamoto S, Takeda Y, Mitsukawa S, Mimura N, Iseki T, Misawa S, Kuwabara S, Nakaseko C, Sakaida E. Shibamiya A, et al. Among authors: kayamori k. Bone Marrow Transplant. 2021 Feb;56(2):517-520. doi: 10.1038/s41409-020-01024-9. Epub 2020 Aug 10. Bone Marrow Transplant. 2021. PMID: 32778687 No abstract available.
Efficacy of the novel tubulin polymerization inhibitor PTC-028 for myelodysplastic syndrome.
Zhong C, Kayamori K, Koide S, Shinoda D, Oshima M, Nakajima-Takagi Y, Nagai Y, Mimura N, Sakaida E, Yamazaki S, Iwano S, Miyawaki A, Ito R, Tohyama K, Yamaguchi K, Furukawa Y, Lennox W, Sheedy J, Weetall M, Iwama A. Zhong C, et al. Among authors: kayamori k. Cancer Sci. 2020 Dec;111(12):4336-4347. doi: 10.1111/cas.14684. Epub 2020 Nov 2. Cancer Sci. 2020. PMID: 33037737 Free PMC article.
DHODH inhibition synergizes with DNA-demethylating agents in the treatment of myelodysplastic syndromes.
Kayamori K, Nagai Y, Zhong C, Kaito S, Shinoda D, Koide S, Kuribayashi W, Oshima M, Nakajima-Takagi Y, Yamashita M, Mimura N, Becker HJ, Izawa K, Yamazaki S, Iwano S, Miyawaki A, Ito R, Tohyama K, Lennox W, Sheedy J, Weetall M, Sakaida E, Yokote K, Iwama A. Kayamori K, et al. Blood Adv. 2021 Jan 26;5(2):438-450. doi: 10.1182/bloodadvances.2020001461. Blood Adv. 2021. PMID: 33496740 Free PMC article.
Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B-cell lymphoma in a Japanese cohort.
Mishina T, Oshima-Hasegawa N, Tsukamoto S, Fukuyo M, Kageyama H, Muto T, Mimura N, Rahmutulla B, Nagai Y, Kayamori K, Hino Y, Mitsukawa S, Takeda Y, Ohwada C, Takeuchi M, Tsujimura H, Iseki T, Nakaseko C, Ikeda JI, Itami M, Yokote K, Ohara O, Kaneda A, Sakaida E. Mishina T, et al. Among authors: kayamori k. Br J Haematol. 2021 Dec;195(5):731-742. doi: 10.1111/bjh.17765. Epub 2021 Aug 10. Br J Haematol. 2021. PMID: 34378195
96 results